Details for Patent: 5,543,408
✉ Email this page to a colleague
Summary for Patent: 5,543,408
| Title: | Crystalline anhydrous mycophenolate mofetil and intravenous formulation thereof |
| Abstract: | The crystalline anhydrous salt formed by complexing mycophenolate mofetil with an anion selected from the group chloride, sulfate, phosphate and acetate (in particular the hydrochloride salt), and pharmaceutical compositions, intravenous formulations and a kit thereof, and associated methods of treatment. |
| Inventor(s): | Roger C. Fu, De-Mei Leung, Jeffrey S. Fleitman, Michele C. Rizzolio, Andrew R. Miksztal |
| Assignee: | Hoffmann La Roche Inc , Syntex USA LLC , Roche Holdings Inc |
| Application Number: | US08/349,236 |
|
Patent Claim Types: see list of patent claims | Composition; Formulation; Device; |
Drugs Protected by US Patent 5,543,408
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,543,408
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 173475 | ⤷ Start Trial | |||
| Australia | 677435 | ⤷ Start Trial | |||
| Australia | 7723894 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
